Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joshua A. Kazam currently holds 350,763 shares of Kite Pharma, Inc. (KITE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joshua A. Kazam has been a net buyer of KITE stock. They have purchased $331.5K and sold $0 worth of shares.
Joshua A. Kazam's most recent insider trade was on Dec 18, 2025, when they sold 47,700 shares at $0.00 per share.
Joshua A. Kazam serves as Executive at Kite Pharma, Inc. (KITE). They have executed 53 insider transactions totaling $331.5K over their tenure at the company.
Joshua A. Kazam holds the position of Executive at Kite Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Joshua A. Kazam has shown a buying trading pattern, with $331.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Joshua A. Kazam was on Oct 3, 2017, when they sold $12.6M worth of KITE shares. This transaction involved 70,050 shares at $180.00 per share.
Joshua A. Kazam currently owns 350,763 shares of Kite Pharma, Inc. (KITE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joshua A. Kazam's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joshua A. Kazam has 53 Form 4 filings on record as an insider at Kite Pharma, Inc..
Set alerts for Joshua A. Kazam and 40,000+ other insiders.